LECIGIMON 20 mg/5 mg/20 mg per ml, intestinal gel 7 cartridges of 47 ml
Active ingredients: (S)-(−)-carbidopa, CARBIDOPA MONOHYDRATÉE, Entacapone, LÉVODOPA
Commercialized according to BDPMDispensing in France: Prescription only
Intestinal gel7 cartridges of 47 mlintestinale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LECIGIMON 20 mg/5 mg/20 mg par mL, gel intestinal
- Pharmaceutical form
- gel intestinal
- Route of administration
- intestinale
- Presentation description
- 7 cartouche(s) polypropylène de 47 ml
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64079868CIP73023561CIP133400930235614Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVODOPAgel | 20 mg · 1 mL de gel | SA |
| CARBIDOPA ANHYDREgel | 4,6 mg · 1 mL de gel | FT |
| CARBIDOPA MONOHYDRATÉEgel | 5 mg · 1 mL de gel | SA |
| ENTACAPONEgel | 20 mg · 1 mL de gel | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.